Literature DB >> 11419742

Simultaneous determination of the histamine H1-receptor antagonist ebastine and its two metabolites, carebastine and hydroxyebastine, in human plasma using high-performance liquid chromatography.

M Matsuda1, Y Mizuki, Y Terauchi.   

Abstract

Ebastine (CAS 90729-43-4) is an antiallergic agent which selectively and potently blocks histamine H1-receptors in vivo. A simple and sensitive high-performance liquid chromatography (HPLC) method is described for the simultaneous determination of ebastine and its two oxidized metabolites, carebastine (CAS 90729-42-3) and hydroxyebastine (M-OH), in human plasma. After a pretreatment of plasma sample by solid-phase extraction, ebastine and its metabolites were analyzed on an HPLC system with ultraviolet detection at 254 nm. Chromatography was performed on a cyano column (250x4.0 mm I.D.) at 40 degrees C with the mobile phase of acetonitrile-methanol-0.012 M ammonium acetate buffer (20:30:48, v/v/v) at a flow rate of 1.2 ml/min. Accurate determinations were possible over the concentration range of 3-1000 ng/ml for the three compounds using 1 ml plasma samples. The intra- and inter-day assay accuracy of this method were within 100+/-15% of nominal values and the precision did not exceed 12.4% of relative standard deviation. The lower limits of quantitation were 3 ng/ml for ebastine and its metabolites in human plasma. This method was satisfactorily applied to the determination of ebastine and its two oxidized metabolites in human plasma after oral administration of ebastine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11419742     DOI: 10.1016/s0378-4347(00)00494-1

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  6 in total

1.  Validated spectroflurimetric determination of some H1 receptor antagonist drugs in pharmaceutical preparations through charge transfer complexation.

Authors:  Mohie K Sharaf el-Din; Fawzia Ibrahim; Manal I Eid; Mary E K Wahba
Journal:  J Fluoresc       Date:  2011-08-10       Impact factor: 2.217

2.  Differential cognitive effects of ebastine and (+)-chlorpheniramine in healthy subjects: correlation between cognitive impairment and plasma drug concentration.

Authors:  Masaaki Tagawa; Michiko Kano; Nobuyuki Okamura; Makoto Higuchi; Michiaki Matsuda; Yasuyuki Mizuki; Hiroyuki Arai; Toshihiko Fujii; Sadao Komemushi; Masatoshi Itoh; Hidetada Sasaki; Takehiko Watanabe; Kazuhiko Yanai
Journal:  Br J Clin Pharmacol       Date:  2002-03       Impact factor: 4.335

3.  Lipid composition and macromolecular crowding effects on CYP2J2-mediated drug metabolism in nanodiscs.

Authors:  Hannah C Huff; Demetri Maroutsos; Aditi Das
Journal:  Protein Sci       Date:  2019-04-01       Impact factor: 6.725

4.  The effect of CYP2J2, CYP3A4, CYP3A5 and the MDR1 polymorphisms and gender on the urinary excretion of the metabolites of the H-receptor antihistamine ebastine: a pilot study.

Authors:  Guillermo Gervasini; Sonia Vizcaino; Juan Antonio Carrillo; Maria Jesus Caballero; Julio Benitez
Journal:  Br J Clin Pharmacol       Date:  2006-08       Impact factor: 4.335

5.  Validated stability-indicating spectrofluorimetric methods for the determination of ebastine in pharmaceutical preparations.

Authors:  Fawzia Ibrahim; Mohie Khaled Sharaf El-Din; Manal Ibrahim Eid; Mary Elias Kamel Wahba
Journal:  Chem Cent J       Date:  2011-03-08       Impact factor: 4.215

6.  Validated stability indicating liquid chromatographic determination of ebastine in pharmaceuticals after pre column derivatization: Application to tablets and content uniformity testing.

Authors:  Fawzia Ibrahim; Mohie Khaled Sharaf El-Din; Manal Ibrahim Eid; Mary Elias Kamel Wahba
Journal:  Chem Cent J       Date:  2011-05-09       Impact factor: 4.215

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.